fluprednisolone has been researched along with Carcinoma, Basal Cell in 1 studies
Fluprednisolone: A synthetic glucocorticoid with anti-inflammatory properties.
Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GRIXONI, F | 1 |
1 other study available for fluprednisolone and Carcinoma, Basal Cell
| Article | Year |
|---|---|
[Histochemical research on metabolism of nucleic acids in basocellular cutaneous epitheliomas treated with epitopic applications of colchicine].
Topics: Carcinoma; Carcinoma, Basal Cell; Colchicine; Fluprednisolone; Humans; Nucleic Acids; Skin Neoplasms | 1953 |